Sophie Jarraud Selected Research

Legionnaires' Disease (Legionnaire's Disease)

9/2020	Comparison of Legionella K-set® and BinaxNOW® Legionella for diagnosing Legionnaires' disease on concentrated urine samples.
1/2020	Persistent Legionnaires' Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms.
1/2020	Transmission of Legionnaires' Disease through Toilet Flushing.
1/2018	KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of trans-Translation Inhibition.
11/2017	Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes.
1/2016	Prospective evaluation of RT-PCR on sputum versus culture, urinary antigens and serology for Legionnaire's disease diagnosis.
9/2015	Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.
11/2011	Extensive recombination events and horizontal gene transfer shaped the Legionella pneumophila genomes.
1/2006	A community-wide outbreak of legionnaires disease linked to industrial cooling towers--how far can contaminated aerosols spread?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Jarraud Research Topics

Disease

10	Infections 01/2021 - 02/2002
9	Legionnaires' Disease (Legionnaire's Disease) 09/2020 - 01/2006
5	Pneumonia (Pneumonitis) 09/2021 - 08/2008
5	Legionellosis 11/2017 - 02/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 07/2009
1	Pleural Effusion (Pleural Effusions) 09/2021
1	Fistula 09/2021
1	Flushing 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Arthritis (Polyarthritis) 10/2019
1	Wounds and Injuries (Trauma) 10/2019
1	Pain (Aches) 10/2019
1	Fever (Fevers) 04/2015
1	Heart Failure 04/2015
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2013
1	Alzheimer Disease (Alzheimer's Disease) 04/2013
1	Central Nervous System Infections (Central Nervous System Infection) 04/2013
1	Neoplasms (Cancer) 07/2009
1	Acute Lung Injury 08/2008
1	Pulmonary Edema 08/2008
1	Aspergillosis 02/2008
1	Endocarditis 02/2002

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2007
3	AerosolsIBA 11/2011 - 01/2006
2	MacrolidesIBA 09/2021 - 02/2007
2	AntigensIBA 09/2020 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019 - 02/2008
1	SpiramycinIBA 09/2021
1	Charcoal (Charbon)IBA 01/2021
1	Growth InhibitorsIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 10/2019
1	asphaltIBA 10/2019
1	tocilizumab (atlizumab)FDA Link 10/2019
1	16S Ribosomal RNAIBA 10/2019
1	Ligases (Synthetase)IBA 10/2019
1	KKL-35IBA 01/2018
1	OxadiazolesIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Biological ProductsIBA 04/2015
1	FlagellinIBA 04/2013
1	CytokinesIBA 04/2013
1	Interleukin-18 (Interleukin 18)IBA 04/2013
1	Pattern Recognition ReceptorsIBA 04/2013
1	InflammasomesIBA 04/2013
1	Type IV Secretion SystemsIBA 02/2010
1	SteroidsIBA 07/2009
1	AlbuminsIBA 08/2008
1	Heparin (Liquaemin)FDA LinkGeneric 08/2008
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2007
1	Erythromycin (Erycette)FDA LinkGeneric 02/2007
1	FluoroquinolonesIBA 02/2007
1	Levofloxacin (Levaquin)FDA Link 02/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Furylfuramide (AF2)IBA 02/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 02/2007
1	Bathroom Equipment 01/2020
1	Intra-Articular Injections 10/2019